ABT as of Oct 31 · 12:15 ET
ABTNYSEPharmaceutical Preparations
Abbott Laboratories · Brief
Next report
82 days
Jan 21 · before openest.
Expected move
Inputs4 of 8≥ implied
- avg implied
- ±3.8%
- avg realized
- ±5.4%
Jan 22 '25±2.9%▲+0.85%×0.29
Apr 16 '25±3.3%▲+2.76%×0.84
Jul 17 '25±3.0%▼−8.52%×2.86
Oct 15 '25±4.3%▼−2.43%×0.57
Jan 22 '26±3.2%▼−10.04%×3.11
Q1 FY26±4.4%▼−6.00%×1.37
Q2 FY26±4.3%▲+10.71%×2.49
Oct 21 '26±5.3%▼−1.89%×0.36
quarterimplied−15%0+15%realized×
Oct '26±5.3%▼−1.89%×0.36
Q2 FY26±4.3%▲+10.71%×2.49
Q1 FY26±4.4%▼−6.00%×1.37
Jan '26±3.2%▼−10.04%×3.11
Oct '25±4.3%▼−2.43%×0.57
Jul '25±3.0%▼−8.52%×2.86
2 older reports
Apr '25±3.3%▲+2.76%×0.84
Jan '25±2.9%▲+0.85%×0.29
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Jan 21 report · est.Bull2 of 4
Bear2 of 3
AI captions · Oct 26 '26once per report · top 2 per case
Linked exposure
ABT report sessionSuppliers 1
× = co-movement · max 501dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.